Allakos Inc. (ALLK)
After hours:
Chart Events
Performance Outlook
| Previous Close | 3.4900 |
| Open | 3.5300 |
| Bid | 3.4600 x 1200 |
| Ask | 3.5400 x 2200 |
| Day's Range | 3.4200 - 3.6650 |
| 52 Week Range | 2.5400 - 112.8700 |
| Volume | |
| Avg. Volume | 1,013,056 |
| Market Cap | 189.237M |
| Beta (5Y Monthly) | 0.96 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.5880 |
| Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.75 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for ALLK
Related Research
- Allakos Inc.Daily – Vickers Top Buyers & Sellers for 03/09/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moatlast yearArgus Research
- GlobeNewswire
Allakos Provides Business Update and Reports First Quarter 2022 Financial Results
REDWOOD CITY, Calif., May 06, 2022 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) and AK006 for the treatment of allergic and inflammatory diseases, today provided a business update and reported financial results for the first quarter ended March 31, 2022. Recent Events Initiated a Phase 2 randomized, double-blind, placebo-controlled study of subcutaneous lirentelimab in patients with moderate-to-severe atopic dermatitis i
- Zacks
Allakos Inc. (ALLK) Stock Sinks As Market Gains: What You Should Know
Allakos Inc. (ALLK) closed at $3.86 in the latest trading session, marking a -1.03% move from the prior day.
- Zacks
Allakos Inc. (ALLK) Gains As Market Dips: What You Should Know
In the latest trading session, Allakos Inc. (ALLK) closed at $5.46, marking a +0.18% move from the previous day.
